Table V.
Disease-free survival | Overall survival | |||||
---|---|---|---|---|---|---|
|
|
|||||
Characteristics | HR | 95% CI | P-value | HR | 95% CI | P-value |
Tumor size (≤2 vs. >2 cm) | 0.115 | 0.044–0.302 | <0.0001 | 0.113 | 0.043–0.298 | <0.0001 |
TNM stage (I–II vs. III–IV) | 1.252 | 0.939–1.668 | 0.126 | 1.243 | 0.932–1.658 | 0.138 |
Axillary lymph node status (negative vs. positive) | 2.897 | 1.897–4.423 | <0.0001 | 2.859 | 1.873–4.362 | <0.0001 |
Recurrence or metastasis (yes vs. no) | 0.649 | 0.426–0.988 | 0.044 | 0.661 | 0.434–1.006 | 0.054 |
Tumor subgroups (TNBC vs. non-TNBC) | 0.190 | 0.127–0.283 | <0.0001 | 0.188 | 0.126–0.280 | <0.0001 |
HR, hazard ratio; CI, confidence interval; TNBC, triple-negative breast cancer.